cyclin dependent kinase 13
| GO Term | Evidence Code | PMID |
|---|---|---|
| alternative mRNA splicing, via spliceosome | ||
| alternative mRNA splicing, via spliceosome | ||
| regulation of signal transduction | ||
| hemopoiesis | ||
| positive regulation of transcription elongation by RNA polymerase II |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cyclin K-CDK13 complex | ||
| extracellular region | ||
| obsolete extracellular space | ||
| nucleus | ||
| nucleoplasm |
| GO Term | Evidence Code | PMID |
|---|---|---|
| RNA binding | ||
| protein kinase activity | ||
| cyclin-dependent protein serine/threonine kinase activity | ||
| protein binding | ||
| ATP binding |
| Gene Ontology |
|---|
| ATP binding |
| RNA polymerase II CTD heptapeptide repeat kinase activity |
| cyclin binding |
| kinase activity |
| nucleotide binding |
| phosphorylation |
| transferase activity |
| InterPro |
|---|
| Protein kinase domain |
| Protein kinase, ATP binding site |
| Protein kinase-like domain superfamily |
| Serine/threonine-protein kinase, active site |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0112247 | congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | |
| DOID:10286 | prostate carcinoma | |
| DOID:1059 | intellectual disability | |
| DOID:684 | hepatocellular carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026